yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q35528797-A441B41E-D31C-4331-9ED4-F15504CA2704
Q35528797-A441B41E-D31C-4331-9ED4-F15504CA2704
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35528797-A441B41E-D31C-4331-9ED4-F15504CA2704
Short commentary on empagliflozin and its potential clinical impact
P2860
Q35528797-A441B41E-D31C-4331-9ED4-F15504CA2704
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35528797-A441B41E-D31C-4331-9ED4-F15504CA2704
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
502c7850572ed135cc87a7b6baf67775cfed1da4
P2860
Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats.